Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry

Publisher: Pleiades Publishing, Ltd.

ISSN PRINT: 1990-7508
ISSN ONLINE: 1990-7516

ABOUT THIS JOURNAL

Publishing model: Hybrid

Authors will have the option to choose how their article is published.

Traditional publishing model: published articles are made available to institutions and individuals who subscribe to this journal or who pay to read specific articles. There is no charge to publish.

Open Access (OA) model: published articles are freely and permanently available online. Anyone, anywhere can read and build upon this research. If you would be interested in publishing Open Access in this journal please follow the link.

Journal Metrics

Usage
  • 19 642Downloads 2023
    Springer measures the usage on the SpringerLink platform according to the COUNTER (Counting Online Usage of NeTworked Electronic Resources) standards.
  • 66 Usage Factor 2022/2023
    The Springer Journal Usage Factor 2022/2023 was calculated as suggested by the COUNTER Code of Practice for Usage Factors. It is the median value of the number of downloads in 2022/2023 for all articles published online in that particular journal during the same time period. The Usage Factor calculation is based on COUNTER-compliant usage data on the SpringerLink platform. (Counting Online Usage of NeTworked Electronic Resources) standards.

Impact
  • 0.6 Impact Factor 2022
    Journal Impact Factors are published each summer by Thomson Reuters via Journal Citation Reports ®. Impact Factors and ranking data are presented for the preceding calendar year.
  • 0.18Source Normalized Impact per Paper (SNIP) 2022
    Source Normalized Impact per Paper (SNIP) measures contextual citation impact by weighting citations based on the total number of citations in a subject field. The impact of a single citation is given higher value in subject areas where citations are less likely, and vice versa.
  • Q4Quartile: Biochemistry 2023
    The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
  • 0.17 SCImago Journal Rank (SJR) 2023
    SCImago Journal Rank (SJR) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.
  • 16H-Index 2023
    A journal has an H index of h if it published h papers each of which has been cited in other journals at least h times. Calculations are based on Scopus.

SCOPE

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry  covers all major aspects of biomedical chemistry and related areas, including proteomics and molecular biology of (patho)physiological processes, biochemistry, neurochemistry, immunochemistry and clinical chemistry, bioinformatics, gene therapy, drug design and delivery, biochemical pharmacology, introduction and advertisement of new (biochemical) methods into experimental and clinical medicine. The journal also publishes review articles. All issues of the journal usually contain solicited reviews.

ABSTRACTING & INDEXING

Baidu, CLOCKSS, CNKI, CNPIEC, Dimensions, EBSCO Discovery Service, EMBASE, EMBiology, Emerging Sources Citation Index, Google Scholar, Japanese Science and Technology Agency (JST), Naver, OCLC WorldCat Discovery Service, Portico, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys, SCImago, SCOPUS, Semantic Scholar, TD Net Discovery Service, UGC-CARE List (India), WTI AG, Wanfang

Contact the journal

Queries about submission issues, peer review process, or the status of your manuscript should be sent to the Editorial Office of Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry: biochmsb@pleiadesonline.com